Project 3 Vaccines

#	NAME OF  VACCINE	DISEASE VACCINE PREVENTS	ANTIGENIC COMPONENTS OF VACCINE	METHOD OF ADMINISTRATION	DURATION OF ANTIBODY
1	Diptheria-Tetanus-Pertussis	Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis	diphtheria toxin and inactivating it with a chemical, the tetanus toxin and inactivating it with a chemical, pertussis vaccine is made by taking two to five of these toxins and inactivating them with a chemical	DTaP and DT are administered to infants, the recommended location for injection is the anterolateral thigh muscle, however, these vaccines can be injected into the deltoid muscle if necessary	DTaP shots are recommended for babies at ages 2, 4, and 6 months, and again at 15 through 18 months of age. A DTaP booster is recommended for children ages 4 through 6 years. The Tdap vaccine is recommended for all 11 through 18 year olds. Adults need to get a Td (tetanus and diphtheria) booster shot every 10 years to stay protected until age 65.
2	Haemophilus influenza Type b	Haemophilus influenzae type b	a preparation of highly purified capsular polysaccharide derived from Haemophilus influenzae type b, which stimulates an immune response in B lymphocytes only	intramuscularly in the vastus lateralis for infants or in the deltoid muscle for toddlers and older children	First Dose: 2 months of age. Second Dose: 4 months of age. Third Dose: 6 months of age (if needed, depending on brand of vaccine). Final Dose: 12-15 months of age.
3	Hepatitis A	Hepatitis A Virus	inactivated whole virus vaccine derived from an attenuated strain of hepatitis A virus grown in cell culture	intramuscularly in the deltoid muscle or the anterolateral thigh	A12 mos -18 yrs: 2 doses 6-12 months apart. 19 years and older: 2 doses 6-12 months apart.
4	Hepatitis B	Hepatitis B Virus (HBV)	hepatitis B surface antigen (HBsAg) inserted into yeast cells	intramuscular	1st injection: at any given time. 2nd injection: at least 1 month after the first dose. 3rd injection: 6 months after the 1st dose.
5	Herpes Zoster	reactivation of latent varicella zoster virus (VZV), shingles	lyophilized preparation of the Oka/Merck strain of live, attenuated VZV	subcutaneously in the deltoid region of the upper arm	one time dose for adults ages 60 and over
6	Human Papillomavirus	Cervical cancer, genital warts	VLP antigens for HPV 16 and 18 reassembled from L1 proteins of HPV 16 and 18	intramuscular	1st dose: now. 2nd dose: 1-2 months after dose 1. 3rd dose: 6 months after dose 1 (Long-lasting)
7	Influenza	Influenza virus	a live attenuated virus vaccine used in immunization against influenza; it is trivalent, usually containing two influenza A virus strains and one influenza B virus strain; injectable flu vaccine, which is either an "inactivated" or "recombinant" vaccine, these vaccines do not contain any live influenza virus	Intramuscular, intranasal, intradermal	Flu vaccination is recommended every year
8	Measles, Mumps, and Rubella	measles virus, mumps virus and rubella virus	live attenuated measles, mumps, and rubella viruses	subcutaneously in the posterolateral fat of the upper arm	Children should get 2 doses of MMR vaccine: First Dose: 12-15 months of age. Second Dose: 4-6 years of age. Some infants younger than 12 months should get a dose of MMR if they are traveling out of the country. Generally, anyone 18 years of age or older who was born after 1956 should get at least one dose of MMR vaccine, unless they can show that they have either been vaccinated or had all three diseases.
9	Meningococcal Infections	Neisseria meningitidis	a preparation of capsular polysaccharide antigen of Neisseria meningitidis	Intramuscular and subcutaneous	Two doses are recommended for adolescents 11 through 18 years of age: the first dose at 11 or 12 years of age, with a booster dose at age 16. Adolescents in this age group with HIV infection should get three doses: 2 doses 2 months apart at 11 or 12 years, plus a booster at age 16. If the first dose (or series) is given between 13 and 15 years of age, the booster should be given between 16 and 18. If the first dose (or series) is given after the 16th birthday, a booster is not needed.
10	Pneumococcal Infections	Streptococcus pneumoniae causing the majority of pneumococcal disease	preparation of purified capsular polysaccharides from the 23 serotypes of Streptococcus pneumoniae causing the majority of pneumococcal disease; used as an active immunizing agent	intramuscular or subcutaneous	Infants/toddlers: 4 shots before the age of 5. Each dosage is given at 2, 4, 6 and 12-15 months of age. Adults: one dosage only or in some cases a second dosage 5 years after the first one.
11	Polio	poliomyelitis	a preparation of a combination of the three types of live, attenuated polioviruses used as an active immunizing agent against poliomyelitis	intramuscular injection in the leg or arm	4 dosages in lifetime: At 2, 4, and 6-18 months of age. A booster at 4-6 years of age.
12	Rotavirus	diarrhea and vomiting caused by rotavirus	live virus vaccine produced from a mixture of four rotavirus types grown in fetal rhesus diploid cells	given by mouth (orally) to young infants	First Dose: 2 months of age. Second Dose: 4 months of age. Third Dose: 6 months of age (if needed)
13	Tetanus	Tetanus (lockjaw) casued by the tetanus bacterium Clostridium tetani	inactivated tetanus toxin (toxoid)	DTaP and DT are administered to infants, the recommended location for injection is the anterolateral thigh muscle, however, these vaccines can be injected into the deltoid muscle if necessary	DTaP shots are recommended for babies at ages 2, 4, and 6 months, and again at 15 through 18 months of age. A DTaP booster is recommended for children ages 4 through 6 years. The Tdap vaccine is recommended for all 11 through 18 year olds. Adults need to get a Td (tetanus and diphtheria) booster shot every 10 years to stay protected until age 65.
14	Varicella	Varicella Zoster Virus (chicken pox)	a preparation of live, attenuated human herpes virus 3 (varicella-zoster virus)	subcutaneously in the posterolateral fat of the upper arm	Children who have never had chickenpox should get 2 doses of the chickenpox vaccine at these ages: 12-15 months of age and 4-6 years of age. People 13 years of age and older (who have never had chickenpox or received chickenpox vaccine) should get two doses at least 28 days apart.
15	Yellow Fever	Virus spread by mosquitoes of the Aedes aegypti species	a preparation of attenuated yellow fever virus	Intramuscularly in the deltoid muscle	Vaccination lasts for 10 years, if you continue to live or travel in yellow fever-endemic areas, you should receive a booster dose of yellow fever vaccine after 10 years.